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Abstract—The amphibian Bv8 and the mammalian prokineticin 1 (PROK1) and 2 (PROK2) are new chemokine-like
protein ligands acting on two G protein-coupled receptors, prokineticin receptor 1 (PKR1) and 2 (PKR2), partici-
pating to the mediation of diverse physiological and pathological processes. Prokineticins (PKs), specifically acti-
vating the prokineticin receptors (PKRs) located in several areas of the central and peripheral nervous system
associated with pain, play a fundamental role in nociception. In this paper, to improve the understanding of
the prokineticin system in the neurobiology of pain, we investigated the role of PKR2 in pain perception using
pkr2 gene-deficient mice. We observed that, compared to wildtype, pkr2-null mice were more resistant to nocicep-
tive sensitization to temperatures ranging from 46 to 48 C, to capsaicin and to protons, highlighting a positive
interaction between PKR2 and the non-selective cation channels TRPV1. Moreover, PKR2 knock-out mice showed
reduced nociceptive response to cold temperature (4 C) and to mustard oil-induced inflammatory hyperalgesia,
suggesting a functional interaction between PKR2 and transient receptor potential ankyrin 1 ion (TRPA1) chan-
nels. This notion was supported by experiments in dorsal root ganglia (DRG) cultures from pkr1 and–pkr2-null
mice, demonstrating that the percentage of Bv8-responsive DRG neurons which were also responsive to mustard
oil was much higher in PKR1/ than in PKR2/mice. Taken together, these findings suggest a functional inter-
action between PKR2 and TRP channels in the development of hyperalgesia. Drugs able to directly or indirectly
block these targets and/or their interactions may represent potential analgesics.  2019 IBRO. Published by Elsevier
Ltd. All rights reserved.Key words: pain, nociception, prokineticin system, prokineticin receptor 2, inflammation.INTRODUCTION
Prokineticins (PKs) are secreted regulatory proteins of
80–90 amino acids that display structural and functional
characteristics similar to those of chemokines. Thehttps://doi.org/10.1016/j.neuroscience.2019.12.003
0306-4522/ 2019 IBRO. Published by Elsevier Ltd. All rights reserved.
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16mammalian prokineticin 1 (PROK1 or endocrine gland-
derived vascular endothelial growth factor, EG-VEGF)
and prokineticin 2 (PROK2 or mammalian Bv8), the
amphibian Bv8 and other homologue proteins of snake
(Mamba Intestinal Toxin-1, MIT-1), lizard and fishes
belong to the prokineticin family. PROK1 and PROK2
are both widely distributed in several organs of the
mammalian body. While PROK1 is predominantly
expressed in non-nervous tissues, especially in
steroidogenic endocrine organs, cardiac and intestinal
tissues, PROK2 is mainly expressed in both the central
(CNS) and peripheral nervous system (PNS), as well as
in the skin, in macrophages, granulocytes or dendritic
cells (Negri and Ferrara, 2018).
PKs bind to two G-protein coupled receptors (GPCR),
termed prokineticin receptor 1 (PKR1) and prokineticin
receptor 2 (PKR2), which are co-expressed in the CNS
and PNS, as well as in granulocytes, macrophages and
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2009). PKR1 is mainly expressed in peripheral tissues
(Soga et al., 2002; Battersby et al., 2004), while PKR2
is more abundantly expressed in several brain regions
(Cheng et al., 2002; Lin et al., 2002), especially in those
associated with pain (Maftei et al., 2014; Franchi et al.,
2017). The activation of PKRs mediates multiple intracel-
lular signalling pathways promoting the mobilization of
intracellular calcium, MAPK, STAT3 and Akt phosphoryla-
tion or cAMP accumulation (Lattanzi et al., 2018; Negri
and Ferrara, 2018).
The wide tissue distribution of PKs and of their
receptors confirms their involvement in several
biological and pathological functions, in particular in
nociception: Bv8 causes significant nociceptive
sensitization to thermal and tactile stimuli at doses in
the femtomolar range (Negri et al., 2002). When injected
by systemic route, Bv8 induces hyperalgesia and allody-
nia with a biphasic time course. The first phase is due
to the activity of PKRs expressed in nociceptors and to
the peripheral release of neuropeptides involved in pain
perception, such as calcitonin gene related peptide
(CGRP) and substance P (Mollay et al., 1999; De Felice
et al., 2012). Conversely, the second phase has a central
origin (Negri et al. 2006; De Felice et al., 2012, Negri and
Maftei, 2018). Of note, PKR1 is mainly expressed in small
nociceptors also expressing the transient receptor poten-
tial vanilloid receptor channel TRPV1, while PKR2 is
mainly expressed in medium/large-sized sensory neu-
rons, co-localized with the transient receptor potential
ankyrin 1 ion channel (TRPA1) (Negri et al., 2006;
Vellani et al., 2006).
The involvement of the PROK2/PKRs system in the
regulation of nociceptive thresholds to acute and chronic
noxious stimuli was demonstrated by studies performed
in prok2- or pkr1-null mutant mice (Hu et al., 2006;
Negri et al., 2006). As demonstrated by Hu et al.
(2006), the lack of the prok2 gene induces a strong reduc-
tion in nociception when the mutant animals are exposed
to thermal and chemical stimuli, in comparison to wild type
(WT) mice. Among the noxious stimuli used, the impaired
nociception exerted by capsaicin treatment was in agree-
ment with the results that demonstrate a potentiation of
capsaicin-evoked pain behaviour by peripheral injection
of PROK2 and Bv8 (Vellani et al., 2006). In addition, the
reduced thermal nociception induced by high noxious
temperatures (46–48 C) in prok2-null mutant mice sug-
gests that PROK2 likely acts through a pathway involving
TRPV1, which is activated in that range of temperatures
(Le Bars et al., 2001; Tominaga and Tominaga, 2005).
However, no difference in local inflammatory response
to capsaicin was observed in prok2 null mutant mice,
which suggests that the function of the chemonociceptive
terminals mediating the acute phase of capsaicin-induced
neurogenic inflammation is unaffected. On the other
hand, a reduced inflammatory pain response to formalin
treatment was observed in prok2-null mutant mice, in
agreement with the literature data reporting central sensi-
tization (likely in the spinal cord) in the formalin model of
persistent inflammatory pain (Abbadie et al., 1997;
Pitcher and Henry, 2002).Studies from pkr1-null mutant mice explored the
role of PKR1 receptors in nociceptive signalling and
in nociceptor sensitization, demonstrating that, when
compared with WT littermates, the lack of pkr1 gene
was able to significantly impair nociception following
exposure to noxious heat, mechanical stimuli,
capsaicin, and protons (Negri et al., 2006). In the
same work it was demonstrated that interaction
between PKR1 and TRPV1, both co-expressed in a
significant proportion of small-diameter neurons in dor-
sal root ganglia (DRG), represents a new example of
GPCR and TRPV1 interaction mediating hyperalgesia
and allodynia (Tominaga and Tominaga, 2005).
Indeed, following both acute and chronic inflammatory
stimuli, pkr1-null mice exhibited reduced development
of hyperalgesia, with a decrease in PROK2 upregula-
tion due to the inflammatory process, as previously
demonstrated (Giannini et al, 2009), confirming the
involvement of the PKR1 receptor in initiating and
maintaining inflammatory pain.
In view of the role of the prokineticin system in pain
and hyperalgesia, the present study aims to further
explore the role of PKR2 receptors in pain perception
following noxious chemical, thermal and inflammatory
stimulation using pkr2-deficient mice.EXPERIMENTAL PROCEDURES
Animals
C57BL/6J WT, PKR1- and PKR2/ male mice,
generated by Lexicon Genetics Incorporated (The
Woodlands, TX, USA) as previously described (Negri
et al., 2006) were used to perform the experiments. Since
PKR2/ mice are not fertile, it was necessary to cross
heterozygous males and females and analyse the geno-
type of littermate pups at weaning, that is, 21 days after
birth (authorization number for mice colony breeding:
116/215-PR). After genotyping, animals were housed five
per cage and maintained under controlled conditions of
light, temperature and humidity (12:12 h light/dark cycles,
21 ± 2 C, 50–60% humidity) with ad libitum access to
food and water.
All experiments were performed on 25–30 g mice
(12–14 weeks old) following protocols approved by the
Animal Care and Use Committee of the Italian Ministry
of Health (authorization number: 116/2015-PR)
according to European Community directives. A total
number of 60 WT, 30 PKR1/ and 70 PKR2/ mice
was used. For each experiment different groups of mice
were used: 5 mice for each genotype for RNA
extraction and genotyping analysis; five mice for each
genotype for histological and immunofluorescence
assays; five mice for each genotype for intracellular
calcium imaging and immunocytochemistry
experiments. The basal sensitivity to different noxious
stimuli was performed on 20 mice for each genotype.
For all the behavioural experiments, involving
pharmacological treatments, groups of five mice for
each genotype and dose were used.
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Genotyping of mouse tails was performed using PCR,
which allowed the amplification of the wild type pkr2
gene (primers: 50-AGCTGCGCAACCTTACCAA-30, 50-G
GGCACGGGCTACCTGT-30) and of the neomycin-
resistant gene cassette, inserted to disrupt the PKR2
coding region (primers: 50-GCAGCGCATCGCCTTC
TATC-30, 50-GGGCACGGGCTACCTGT-30). Genomic
DNA was extracted from mouse tail samples by
overnight digestion with proteinase K (Sigma, Milan,
Italy), precipitated with ethanol, dried and dissolved in
sterile water. PCR amplification was obtained using
200 ng of DNA in 25 ll of total reaction volume, using
HotStarTaq DNA Polymerase (Qiagen, Milan, Italy) in
the presence of the specific primers listed above. The
amplification temperature profile used was: 1 cycle at
95 C for 3 min (denaturation); followed by 30 cycles of
95 C for 1 min, 55 C for 1 min (annealing), 72 C for
1 min; and 1 cycle 72 C for 10 min (extension).
Amplified products were resolved on 2% agarose gel,
stained with ethidium bromide, and visualized with
Versa Doc 3000 imaging system (Bio-Rad, Milan, Italy).RNA extraction and real-time PCR
Total mRNA from DRG of wild type and pkr2-null mice
(n= 5 animals per genotype) was extracted using
RNeasy columns (Qiagen) following the manufacturer’s
protocol. The total amount of mRNA was
spectrophotometrically quantified, and 1 lg of mRNA
was reverse transcribed to obtain cDNA, using the
reverse transcriptase from (Promega, Milan, Italy). The
cDNA aliquots were then amplified in real-time PCR
(iCycler; Bio-Rad) using the iQ SYBR Green Supermix
(Bio-Rad) in the presence of the specific primers
(0.3 lM of each primer) for the target genes: PKR1,
PKR2, TPRV1 and TRPA1, in a total reaction volume of
25 ll. The real time PCR was carried out using the
following thermal protocol: 1 cycle at 95 C for 15 min;
followed by 40 cycles at 95 C for 30 s, 52 C for 30 s,
and at 72 C for 30 s. For each PCR product a melting
curve analysis from 55 to 95 C was performed. The
specific sense and antisense mouse primers (Biogen,
Rome, Italy) used for PCR are reported below:
PKR1, 50-ATTCTCGGACTTTCTTTGC-30 and 50-GC
GGCTGTTTGACACTTC-30
PKR2, 50-ACTACCTTCGTACGGTCTCC-30 and 50-TA
ACGAGGATGGTTTCTGTG- 30
TRPV1, 50-TGTACTTCAGCCATCGCAAG-30 and 50-A
CCGACACAGGTCTCTGAGG-30
TRPA1, 50-CTACTGGCTTTTGGCCTCAG-30 and 50-C
CAAAGGTCAGGACTGGGTA-30
To quantify the results, using the same primers as
described above, cDNA standards for each individual
gene were generated from total RNA extracted from
mouse DRG. Once produced, the cDNA fragments were
purified using silica columns (QIAquick PCR purification;
Qiagen), cloned into a pGEM-T easy vector (Promega)
and ligated fragments were transformed using JM109-competent cells (Promega). The cloned plasmid cDNA
was further purified with silica cartridges (Nucleobond
AX plasmid purification; Macherey-Nagel, Duren,
Germany) and the cloned amplicons sequences were
analysed using cycle sequencing (PRIMM, Milan, Italy).
The concentration of plasmid cDNA was determined by
spectrophotometer (OD260nm) and the corresponding
copy number was calculated with the following equation:
1 lg of 1000 bpDNA= 9.1  1011 molecules. Plasmid
cDNA was serially diluted, from 102 to 107 input copies,
to generate a standard curve, which was amplified in
each real time PCR run. The expression level of the
gene of interest was expressed as input copy number
per nanogram of input total RNA.Immunofluorescence
Immunofluorescence was performed as previously
described (Maftei et al., 2014). Briefly, the L4-L5 DRG
were dissected from WT, PKR1/ and PKR2/ mice
(n= 5 animals per genotype), previously transcardially
perfused with PBS followed by 4% paraformaldehyde
(PFA). The collected tissue was further post-fixed in 4%
PFA for 24 h, cryoprotected in 30% sucrose solution
and cut in 20 lm thick slices. The DRG slices were
blocked for 30 min at room temperature using 3% normal
donkey serum dissolved in PBS/0.3% triton X-100 and
then incubated overnight at 4 C with anti-PKR2 antibody
(rabbit, 1:200, Alomone labs, Jerusalem, Israel) diluted in
PBS/0.3% triton X-100. Section were rinsed in PBS and
then incubated with the proper secondary antibody (anti-
rabbit IgG coupled to Alexa Fluor-488, Immunological
Sciences) for 2 h at room temperature. The staining of
nuclei was performed with DAPI (1:500, Sigma Aldrich).
Images were visualized and acquired with a laser-
scanning confocal microscope (Leica SP5, Leica
Microsystems, Wetzlar, Germany) connected to a digital
camera diagnostic instruments operated by I.A.S. soft-
ware of Delta Systems Italia (Milan, Italy).Immunohistochemistry
The assay was performed on L4-L5 DRG dissected from
WT and PKR2/ mice (n= 5 animals per genotype) as
previously described (Artico et al., 2010). Briefly, DRG
were fixed in 10% formaldehyde solution, embedded in
paraffin and serially cut (7 lm thickness). Sections
(n= 12–17 from each DRG) were deparaffinized, rehy-
drated and blocked for endogenous peroxidases (incuba-
tion in H2O2 0.3% diluted in methanol) for 30 min. After
antigen retrieval (heated in 10 mM citrate buffer pH 6.0
for 10 min) sections were incubated overnight at 4 C,
with the primary antibody mouse anti-NeuN (1:200,
Sigma, Milan, Italy) rinsed and then incubated for 1 h at
room temperature with the appropriate secondary anti-
body (1:100) conjugated to horseradish peroxidase
(HRP, Cell Signalling). After a further wash with PBS,
slides were treated with 3,3-diaminobenzidine (0.1 mg/
ml, Dako) for 10 min. Finally, sections were counter-
stained with 0.1% o-toluidine blue solution at pH 4.5.
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Nociceptive behaviour differences to noxious stimuli such
as heat, punctate filaments, acetic acid, capsaicin and
formalin were measured in WT and PKR2/ mice. A
different group of mice from each genotype was used
for each nociceptive test.
– Thermal nociception was evaluated by hot plate, tail
and paw immersion tests (Negri et al., 2006).
Hot plate test was performed by placing the animal on
a hot plate (Ugo Basile, Italy) with temperature ranging
from 46 to 52 C. The time to the first sign of
nociception such as paw licking, flinching, jumping and
escaping from the hot plate was recorded and the
animal was immediately removed.
Tail and paw immersion tests were carried out by
briefly immersing the tail or one hindpaw of the mouse
into a hot (46, 48 and 52 C) or cold (4 C) water bath.
The time, in seconds, for tail/paw withdrawal from the
water was recorded. To reduce variability in nociceptive
threshold measurements, three days before the
experiments mice were trained in tail-or paw withdrawal
tests at 30 min intervals for 3 h daily. Mice showing non-
homogeneous baseline values were discarded.
– Mechanical nociception: tactile allodynia was
performed using von Frey filaments with logarithmically
incrementing stiffness (0.04–2.0 g, 2 Biological
Instruments, Besozzo, Varese, Italy). Mice were placed
on a mesh grid and after a 30 minute period of
habituation the filaments were perpendicularly applied to
the plantar surface of mouse paw for 7–8 s. The 50%
paw withdrawal threshold (PWT) was determined using
Dixon’s up-down paradigm (Chaplan et al., 1994).
– Chemical nociception: acetic acid-induced writhing
test was used to asses visceral pain. Briefly, mice were
intraperitoneally injected with 0.8% acetic acid solution
(5 ml/kg body weight) and the number of abdominal
constrictions were counted for 20 min. Capsaicin test:
capsaicin (1.5 lg in 20 ll) was injected into the plantar
surface of the mouse hindpaw and the time (seconds, s)
spent licking, flinching or biting the paw was measured
for 15 min after injection. Formalin test: 5% of formalin
solution (20 ll) was injected into dorsal surface of
mouse hindpaw and the time (s) spent licking, flinching
or biting the paw was measured for each 5 min interval
during the early phase (0–10 min) and the late phase
(10–60 min).Measurement of nociceptive sensitization
The nociceptive sensitization produced by the pro-algesic
agents such as Bv8 and capsaicin or that produced by
acute and chronic paw inflammation were measured in
WT, pkr1- and pkr2-null mutant mice, as changes in
nociceptive threshold to noxious or non-noxious sensory
stimuli. Thermal hyperalgesia was assessed using hot-
plate and paw immersion test (48 C); while tactile
allodynia was assessed using von Frey filaments.
Bv8-induced hyperalgesia: was elicited by
subcutaneously (s.c., 5 ml/kg b.w.), in doses ranging
from 1 to 30 lg/kg, and intraplantar (i.pl., 20 ll), in
doses ranging from 0.5 to 5 ng/paw, injection of Bv8.Capsaicin-induced thermal hyperalgesia: was elicited by
intraplantar injection of capsaicin (12 lg).
Paw inflammation was elicited by plantar painting with
mustard oil (MO) (10% in mineral oil; Sigma-Aldrich,
Milan, Italy) or intraplantar injection of Complete
Freund’s Adjuvant (20 ll CFA, Sigma-Aldrich, Milan,
Italy).
Changes of nociceptive thermal and mechanical
thresholds after the pro-algesic and pro-inflammatory
agents injection were calculated and expressed as
percentage change in nociceptive threshold from
baseline threshold %DNT= 100  (NTts – NTb)/NTb
where NTb is the baseline nociceptive threshold and
NTts is the nociceptive threshold in the presence of the
pro-algesic/ pro-inflammatory agent.Body temperature
Mice body temperature was assessed using implantable
thermal probes (G2 E-Mitter probe; ER-4000 Energizer
receiver; Vital View software; Mini Mitter, Sunriver, OR).
To introduce the probe into the peritoneal cavity, mice
were, firstly, anesthetized with an intraperitoneal
injection of ketamine (60 mg/kg) and xylazine (10 mg/
kg). Subsequently, an incision at the linea alba was
made, probe was inserted, sutured to the inner
musculature and finally the incision was closed. This
procedure, showing a very low risk of internal
displacement of the sensor, permitted us a continuous
and accurate monitoring of mice body temperature.
Prior experiment the core body temperature in wild type
and pkr2-null mutant mice was continuously monitoring
for 1 week. On the day of the experiment capsaicin
(1 mg/kg) was s.c. administrated in both WT and
PKR2/ mice and the body temperature was recorded
for 3 h.Intracellular calcium imaging and
immunocytochemistry in DRG cultures
Sensory neurons were isolated from mice and cultured as
previously described (Vellani et al., 2004, 2006). Animals
were killed by cervical dislocation and decapitation under
CO2 anaesthesia. DRGs were incubated for 60 min at
37 C with 0.125% type IV collagenase (Worthington,
Freehold, NJ), mechanically dissociated and plated onto
coverslips pre-treated with 10 lg/ml poly-L-lysine (Sigma,
St. Louis, MO) and 20 lg/ml laminin (Sigma). The med-
ium was DMEM with 1% penicillin/streptomycin, 10% fetal
bovine serum, 1% l-glutamine (Invitrogen, San Diego,
CA), 1.5 lg/ml cytosine 1-b-D-arabinofuranoside (Sigma),
and 100 ng/ml NGF (2.5S NGF; Invitrogen). After 3 days
in vitro, cells were loaded with the calcium-sensitive fluo-
rescent dye Fluo-4 AM (10 lm for 10 min, Invitrogen), and
experiments performed with an imaging setup equipped
with a Cairn monochromator and an electron-multiplying
CCD camera with proprietary acquisition software (Andor
Technology). During the experiments cells were continu-
ously superfused with HBSS (140 mM NaCl, 1.8 mM
CaCl2, 1 mM MgCl2, 4 mM KCl, 10 mM HEPES, 4 mM
glucose, pH 7.4). Treatments were applied with an auto-
mated fast solution changer based on a stepping motor
Fig. 1. Mouse tail DNA genotyping, DRG PKR2 protein localization and DRG mRNA expression of
PKR1, PKR2, TRPV1 and TRPA1 genes. (A) Representative example of WT (PKR2+/+),
heterozygous mutant (PKR2+/) and homozygous mutant (PKR2/) mouse tail DNA genotyped
by PCR. Lane WT contains PCR amplification products of the wild-type PKR2 gene; lane NEO
contains the PCR amplification products of the mutant gene; lanes WT contain the PCR amplification
products obtained with primers for wild-type PKR2 gene; lanes NEO contain the PCR amplification
products obtained with primers for the mutant gene; lanes WT+ NEO indicate multiplex PCR for both
the WT and the mutant gene; lane M contains DNA molecular weight markers. (B) Immunofluores-
cence staining showing the presence of PKR2 (arrows) in DRG neurons from WT and PKR1/mice
but not in DRG neurons from PKR2/ mice. Scale bar = 20 lm. (C) Expression of PKR1, PKR2,
TRPV1 and TRPA1 genes in DRG from WT and PKR2/ mice (n= 5 mice/genotype for DNA/RNA
extraction; n= 5 mice/genotype for immunofluorescence).
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Modena, Italy). Neuronal cells were routinely distin-
guished from satellite/glial cells present in DRG cultures
by morphology and by their fluorescence response to a
brief puff of HBS containing an increased extracellularpotassium concentration (25 mM)
which causes depolarization and
activation of the voltage-sensitive
calcium channels expressed in
neurons (not shown). At the end
of the experiment, the maximal flu-
orescence (Fmax) was obtained
with the application of the calcium
ionophore ionomycin (10 lm; Cal-
biochem, La Jolla, CA) in the pres-
ence of high calcium (30 mM) and
high potassium (125 mM). The flu-
orescence individual neurons was
carefully analysed offline with Ima-
geJ (EMBL, Heidelberg, DE)
(Vellani et al., 2006). Sensitisation
of the capsaicin response was
investigated with an experimental
approach similar to the one used
in Bonnington and McNaughton
(2004), as described in Results.
Fluorescence is expressed as F/
Fmax. All experiments were per-
formed at room temperature (RT)
(20–22 C).Statistical analysis
Statistical analysis and graphing
were performed using GraphPad
Prism software (Version 6) or
Sigmaplot 10.0. Unpaired
Student’s t-test (two-tailed
distribution and equal variance)
was used to perform the statistical
analysis between groups. Two-
way ANOVA test was used to
analyse the behavioural time-
course data; the significant
interactions were further subjected
to Bonferroni’s post-hoc test for
multiple comparisons (data
normally distributed, equal
variance). All data were
expressed as mean ± SEM
values. Statistical analysis at
p< 0.05 (*) were considered
significant.RESULTS
CharacterizationofPKR2/mice
As shown in Fig. 1A, mouse tail
DNA genotyping confirmed the
complete absence of the pkr2
gene sequence.
Immunofluorescence studies
(Fig. 1B) confirmed the totalabsence of PKR2 protein in DRG neurons, where
normally both PKRs are expressed and produce
hyperalgesia by sensitizing TRPV1 and TRPA1 (Vellani
Fig. 2. Nociceptive responses of PKR2/ mice to thermal and tactile stimuli. (A) PKR2/ mice
exhibited significantly increased paw withdrawal latencies from hot plate and (B) increased tail
withdrawal latencies from cold and hot water in comparison to WT mice (tail immersion test) (C) Paw
withdrawal latency from both hot and cold water and (D) tactile threshold by von Frey filaments did not
reveal any difference between the two genotypes. Data are shown as mean ± SEM, ***p< 0.001 vs
WT unpaired Student’s t-test. For all behavioural test 20 WT and 20 PKR2/ mice were used.
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DRG-extracted RNA, we determined that in WT ani-
malsPKR1 mRNA is 8 times higher than PKR2, and about
4 and 2 times lower than TRPV1 and TRPA1 mRNA. In
PKR2/ mice instead, PKR2 mRNA was completely
absent while PKR1, TRPV1 and TRPA1 transcripts were
present at the same WT levels (Fig. 1C).Impaired thermal and mechanical nociception in
PKR2/ mice
The sensitivity of WT and PKR2/ mice to noxious,
thermal and mechanical stimuli were assessed with
behavioural experiments.
When exposed to noxious heat and cold, pkr2-null
mutant mice showed a reduced nociceptive response. In
the hot plate test at 52 C there were no significant
differences in the response latencies of the two
genotypes (WT and PKR2/ mice) (t(37) = 1.93,
p= 0.061), while at lower temperature (<50 C)
PKR2/ mice displayed significantly longer (about 2-
fold) response latencies (Fig. 2A, t(38) = 8.17,
p< 0.0001 at 46 C and t(38) = 12.12, p< 0.0001 at
48 C). A comparable reduced response was observed
in the test using hot water (46–48 C) applied to the
mouse tail. Also in this case the response latencies at
46 and 48 C were  2-fold longer in pkr2-null mutant
compared with the WT littermates (t(38) = 7.95,
p< 0.0001 and t(38) = 9.67, p< 0.0001, respectively),
while no differences were observed at 52 C (t(38)= 1.58, p= 0.12). Analogously,
pkr2 deletion produced a
significantly impaired response to
cold stimuli (immersion of the
mouse tail in cold water at 4 C) (t
(36) = 7.29, p< 0.0001), as
revealed by the increased
latencies in pkr2-null mutant mice
(Fig. 2B). On the contrary, no
significant differences were
detected in the withdrawal
latencies between PKR2/ and
WT mice when both cold (4 C)
and hot (46–52 C) water tests
were applied to the mouse paw
(Fig. 2C, t(40) = 1.45, p= 0.15
at 4 C; t(38) = 1.84, p= 0.07 at
46 C; t(38) = 1.6, p= 0.11 at
48 C; t(37) = 1.76, p= 0.085 at
52 C). Similarly, no significant
differences in paw withdrawal
threshold to tactile stimuli,
assessed with von Frey filaments,
was observed between PKR2/
and WT mice (Fig. 2D, t(38)
= 1.99, p= 0.053).
Overall, these data indicate
that pkr2 deletion alters baseline
sensitivity to thermal stimuli,
leaving unaltered tactile
nociception in the tested
conditions.Reduced nociceptive response to noxious chemical
stimuli in PKR2/ mice
The same reduced nocifensive behaviour was observed
in the PKR2/ genotype following noxious chemical
stimuli such as intra-peritoneum (i.p.) acetic acid and
intra-plantar (i.pl.) capsaicin injection. As shown in
Fig. 3A, compared to WT, in PKR2/ mice the
writhing episodes after acetic acid treatment were
significantly less intense and shorter-lasting (t(8)
= 4.89, p= 0.0012). Also paw shaking, licking and
biting after capsaicin treatment were significantly
reduced (Fig. 3B, t(8) = 17.84, p< 0.0001).
Subcutaneous (s.c.) hindpaw inoculations of formalin
in mice is characterized by a biphasic behavioural
response, a first short-lived phase of 0–10 min and a
subsequent sustained phase of 10–50 min of duration
(Hunskaar et al., 1986; Coderre et al., 1990).
In PKR2/ mice both the early and late phase
responses to subcutaneous formalin administration were
significantly smaller when compared to the ones
observed in WT mice (t(8) = 5.12, p= 0.0009 early
phase and t(8) = 3.503, p< 0.008 late phase).
Conversely, PKR1/ mice showed a significant
reduction only in the early phase response, compared to
WT (t(8) = 3.37, p= 0.009 early phase and t(8)
= 0.79, p= 0.44 late phase), thus demonstrating a
significant difference in the nociceptive response
between the two null genotypes, pkr1 and pkr2, only in
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(8) = 2.51, p= 0.035 late phase).Impaired nociceptive sensitization by proalgesic
agents in PKR2/ mice
As previously demonstrated, the s.c (1 lg/kg) and i.pl
(0.5 ng) injection of Bv8 induced powerful and long-
lasting sensitization to thermal stimuli (Negri et al.,
2006). We demonstrated that pkr2-null mice were also
responsive to Bv8 treatment, however a 30 times higher
s.c. (Fig. 4A; Time: F(13,209) = 66.92, p< 0.0001;
Group: F(2,209) = 84,17, p< 0.0001; Interaction:
F(26,209) = 17.08, p< 0.0001; post-hoc p< 0.001
PKR2/: 1 vs WT:1) and a 10 times higher i.pl. Bv8
dose were necessary to obtain a similar level of hyperal-
gesia (Fig. 4B; Time: F(7,119) = 61.79, p< 0.0001;
Group: F(2,119) = 56.47, p< 0.0001; Interaction:
F(14,119) = 10.97, p< 0.0001; post-hoc p< 0.001
PKR2/: 0.5 vs WT:0.5).
Deletion of pkr2 was also involved in allodynia induced
by Bv8 i.pl. injection. Whereas 0.5 ng of Bv8 evoked
tactile allodynia in WT mice, a 10 times higher Bv8 dose
was necessary to obtain the same effect in pkr2-null
mice (Time: F(7,119) = 87.44, p< 0.0001; Group: F
(2,119) = 157.27, p< 0.0001; Interaction: F(14,119) =
20.71, p< 0.0001; post-hoc p< 0.001 PKR2/: 0.5
vs WT:0.5). Interestingly, the Bv8 dose effective in WT
animals (0.5 ng) was also able to evoke tactile allodynia
in pkr1-null mice (Time: F(7,79) = 72.75, p< 0.0001;
Group: F(1,79) = 11.61, p= 0.001; Interaction: F(7,79)
= 3.23, p= 0.0053; p< 0.01 PKR1/: 0.5 vs
WT:0.5) (Fig. 4C).
In addition, nociceptive sensitization to thermal stimuli
(48 C, paw immersion) induced by intrapaw injection of
capsaicin (12 lg) in WT mice, was absent in pkr2-null
mice (Fig. 4D) (Time: F(6,69) = 41.88, p< 0.0001;
Group: F(1,69) = 53.39, p< 0.0001; Interaction: F(6,69)
= 13.82, p< 0.0001; post-hoc p< 0.001 PKR2/ vs
WT).
On the whole, these results show that only pkr2
deletion, but not pkr1 deletion, impaired tactile allodynia.Fig. 3. Nociceptive responses of PKR2/mice to noxious chemical
stimuli. (A) PKR2/ mice showed a reduced number of writhes in
response to intraperitoneal 0.8 % acetic acid injection compared with
WT mice during the 20 min observation period (n= 5 mice/geno-
type). (B) Paw licking recorded for 10 min after 1.5 lg intraplantar
capsaicin injection was shorter in pkr2-null mice than in WT mice
(n= 5 mice/genotype). (C) PKR2/ mice exhibited significantly
increased early phase response to subcutaneous administration of
5% formalin; the late phase response did not show significant
difference between WT and PKR2/ mice. Data are shown as
mean ± SEM (n= 5 mice/genotype). Unpaired Student’s t-test:
**p< 0.01, ***p< 0.001 vs WT; p< 0.05 vs PKR1/.Lacking of inflammatory hyperalgesia in PKR2/
mice
We tested the sensibility of pkr2-null mice to both acute
and chronic inflammatory hyperalgesia.
Acute inflammatory hyperalgesia was obtained
painting mustard oil solution on both hindpaws, and
noxious response measured with the hot-plate test. As
shown in Fig. 5A, mustard oil-induced thermal
hyperalgesia was evident within 15 min after application
in WT mice, reaching its maximum after 30 min
(40 ± 3% of the baseline paw withdrawal latency) and
lasted up to 80–90 min. In pkr2-null mice the thermal
nociceptive threshold remained at the baseline values
(Time: F(5,59) = 16.92, p< 0.0001; Group: F(1,59)
= 17.74, p= 0.0029; Interaction: F(5,59) = 11.21,
p< 0.0001; post-hoc p< 0.001 PKR2/ vs WT),
while in PKR1/ mice a significant reduction
(24 ± 3%) of the baseline paw withdrawal latency wasobserved (Time: F(5,59) = 34.99, p< 0.0001; Group: F
(1,59) = 5.52, p= 0.046; Interaction: F(5,59) = 4.38,
p= 0.0028; post-hoc p< 0.01 PKR1/ vs WT).
Chronic inflammatory hyperalgesia was induced by i.
pl. injection of CFA, and tested analysing paw-
withdrawal latency to noxious thermal (paw immersion
test at 48 C) and tactile stimuli (Von-Frey filaments) 6,
24, 36, 48, 60 and 72 h after CFA administration. The
results showed that the development of CFA-induced
thermal hyperalgesia was impeded by the disruption of
pkr1 as well as pkr2 genes (Fig. 5B; Time: F(5,89)
= 47.79, p< 0.0001; Group: F(2,89) = 91.85,
p< 0.0001; Interaction: F(10,89) = 28.54, p< 0.0001;
post-hoc p< 0.001 PKR1/ vs WT and PKR2/ vs
WT), while only the pkr2 disruption blocked the
development of CFA-induced tactile allodynia (Fig. 5C;
Time: F(8,134) = 150.22, p< 0.0001; Group: F(2,134)
= 107.23, p< 0.0001; Interaction: F(16,134) = 21.56,
p< 0.0001; post-hoc p< 0.001 PKR2/ vs WT).
Fig. 4. Nociceptive responses of PKR2/ mice to pro-algesic agents. (A) In WT mice, subcuta-
neous injection of Bv8 (1 lg/kg) produced a long-lasting sensitization to thermal stimuli (hot-plate
test). A 30-fold higher dose was necessary to obtain the same effect in PKR2/ mice (n= 5 mice/
genotype/dose). (B) In WT mice, intraplantar (0.5 ng) administration of Bv8 induced thermal
hyperalgesia in the injected paw without affecting the contralateral paw (paw-immersion test, 48 C). A
10-fold higher dose of Bv8 was required to elicit hyperalgesic effects comparable to those obtained in
WT mice. (C) In WT mice the intraplantar injection of 0.5 ng Bv8 evoked tactile allodynia (Von-Frey
filaments); the same dose was effective in PKR1/mice but not in PKR2/mice, where a 10 times
higher Bv8 dose was necessary to obtain the same effect (n= 5 mice/genotype/dose). (D)
Intraplantar injection of capsaicin (12 lg) induced sensitization to thermal stimuli in WT but not in
PKR2-null mice (paw immersion test, 48 C). Data are shown as mean ± SEM (n= 5 mice/
genotype/dose). Two-way ANOVA for repeated measures followed by Bonferroni’s post hoc test for
multiple comparisons: *p< 0.05, **p< 0.01, ***p< 0.001 vs WT.
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mice
Systemic capsaicin, by selectively activating chemo- and
heat-sensitive TRPV1 receptors, exerts significant effect
on thermoregulation, reducing body temperature. By s.c.
injection, capsaicin (1 mg/kg) lowered body temperature
by about 6 C in WT animals, while in PKR2/ mice
reduction was about 1 C (Fig. 6; Time: F(11,119)
= 58.31, p< 0.0001; Group: F(1,119) = 4.23,
p< 0.073; Interaction: F(11,119) = 20.2, p< 0.0001;
post-hoc p< 0.001 PKR2/ vs WT).
Morphology of DRG neurons from PKR2/ mice
We tested the influence of pkr2 gene deletion in DRGs,
analysing their morphology. As shown in Fig. 7A, B,
immunostaining for neuronal cells showed no significant
differences in morphology of DRGs from PKR2/
mice, compared to WT mice.
Calcium response in cultured mouse DRG neurons
The functional expression of TRPV1 and TRPA1, and
their co-expression with functional PKR receptors wasstudied with calcium imaging in
PKR2/, PKR1/ and WT
cultured DRG neurons. The
specific agonists capsaicin
(600 nM) and mustard oil (MO,
1 mM) were used to elicit specific
TRPV1- and TRPA1-mediated
calcium signals.
The percentage of TRPV1- and
TRPA1-positive neurons in the
three genotypes tested is
summarised in Fig. 9A. The
fraction of the capsaicin-
responsive neurons was reduced
by more than 50% in both
PKR2/ and PKR1/ in
comparison with WT. Similarly,
MO-responsive neurons were
reduced in both transgenics,
although to a lesser extent in
PKR1/ (Fig. 9A). This indicates
a significant role of PKRs in
functional expression of both
TRPV1 and TRPA1 in sensory
neurons.
The Bv8-responsive
subpopulation of cultured DRG
neurons was detected as the
subpopulation that responded to
Bv8 (100 nM, 1 min), either with a
direct calcium signal (not shown),
or with the sensitization of their
response to capsaicin (Vellani
et al., 2006). When present, the
calcium response to Bv8 treatment
was typically delayed (3–29 s from
the beginning of Bv8 treatment)
and large (DF> 0.12 Fmax), simi-
lar to the response to Bv8 shownpreviously in the rat (Vellani et al., 2006).
The sensitization of the capsaicin response following
Bv8 application was studied with an experimental
protocol similar to the one described in Bonnington and
McNaughton (2003). A brief puff of capsaicin (500 nM,
600 ms duration) was repeatedly applied at 2 min inter-
vals with an automated multibarrel fast solution changer
during continuous superfusion with vehicle solution. After
some initial adaptation, the capsaicin responses became
more reproducible. The test solution containing Bv8
(100 nM for 1 min) was applied between the 5th and 6th
capsaicin pulse. In control experiments, the vehicle solu-
tion was applied with the same perfusion protocol used for
the test solution containing Bv8. The vehicle treatment
per se did not produce any response, ruling out mechan-
ical artefacts due to solution turbulence. The response of
individual capsaicin-sensitive neurons was carefully
quantified offline. The calculated ratios between the 6th
and the 5th capsaicin response amplitudes measured in
experiments with vehicle were normally distributed, and
from the mean and standard deviation of the control distri-
bution a threshold level for classifying a neuron as exhibit-
Fig. 5. Inflammatory hyperalgesia in PKR2/ mice. (A) Acute
inflammatory hyperalgesia (hot-plate test), induced by painting both
hindpaws with mustard oil was intense in WT mice and was impaired
in PKR1/ mice, while PKR2/ mice were completely unaffected
(n= 5 mice/genotype/dose). (B, C) Chronic inflammatory hyperal-
gesia elicited by intrapaw injection of CFA was impaired in PKR2/
mice when both thermal (paw immersion, 48 C, (B)) and tactile (Von-
Frey filaments, (C)) were applied to the paw. Pkr1-null mice exhibited
reduced inflammatory thermal but not tactile CFA-induced hyperal-
gesia. Data are shown as mean ± SEM (n= 5 mice/geno-
type/dose). Two-way ANOVA for repeated measures followed by
Bonferroni’s post hoc test for multiple comparisons: *p< 0.05,
**p< 0.01, ***p< 0.001 vs WT.
Fig. 6. Impaired capsaicin-induced hypothermia in PKR2/ mutant
mice. Subcutaneous capsaicin (1 mg/kg) induced hypothermic
response in WT but not in PKR2/ mice. Data are shown as
mean ± SEM (n= 5 mice/genotype/dose). Two-way ANOVA for
repeated measures followed by Bonferroni’s post hoc test for multiple
comparisons: **p< 0.01, ***p< 0.001 vs WT.
Fig. 7. Morphology of DRG neurons in PKR2/ mice. Micropho-
tographs of DRG sections from PKR2/ (A) and WT mice (B),
immunostained with an antibody specific for the neuronal marker
NeuN and stained with 0.1% o-toluidine blue. The images demon-
strate no differences in the morphology of DRG fromWT and PKR2/
 mice (n= 5 mice/genotype/dose).
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lated two-tailed 99.9% confidence value of 1.62 (Fig. 8B,
left panel). As expected, in Bv8-treated cells a normallydistributed population of 6th/5th ratio values similar to the
one in control experiments was observed, together with
a subpopulation of values above 1.62 (range: 1.85–8),
indicating sensitization of the capsaicin response by Bv8
(Fig. 8B, right panel).
At the end of capsaicin pulse protocol, the TRPA1
agonist allyl isothiocyanate (mustard oil, 10 mM, 30 s),
was applied to test for co-localization of Bv8 response
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and TRPA1, demonstrating the co-localization of Bv8
response effect only with TRPA1 from neurons of
PKR1-null mice, where PKR2s are expressed (Fig. 8C).
The total percentage of Bv8-responsive DRG neurons
(either with a calcium signal and/or with sensitization to
capsaicin in response to Bv8) was 11.6% in PKR2/,
5.3% in PKR1/, and 18.3% in WT cultures (Fig. 9).
The percentage of Bv8-responsive neurons which were
also responsive to capsaicin was identical in PKR1/
and PKR2/ mice (Fig. 9B) but significantly smaller
compared to WT neurons. Conversely, the percentage
of Bv8-responsive DRG neurons which were also
responsive to MO was much higher in PKR1/ than in
PKR2/ mice (Fig. 9B). All differences mentioned
were statistically significant, as assessed by v2 analysis.Fig. 8. Sensitization of the capsaicin response by Bv8. (A) Calcium
responses of cultured sensory neurons during pulsed applications of
capsaicin (500 nM, 600 ms), Bv8 (50 nM, 1 min) and mustard oil (MO,
1 lM, applied for 20–40 s). In neurons insensitive to Bv8 (upper
panel) the capsaicin response was unaffected by Bv8. Examples of
neuronal calcium responses to capsaicin sensitized by Bv8 are
shown in the middle (PKR1/ neuron also responsive to MO) and
lower panel (PKR2/ neuron unresponsive to MO). Individual
responses of Bv8-sensitive neurons from WT mice displayed a
largely similar behaviour (not shown). (B) Distribution of the calcu-
lated ratios between the 6th and the 5th capsaicin response amplitude
in PKR2/ neurons treated with vehicle (left panel) or with Bv8
(right panel, experiments as in (A)). The Bv8-responsive neurons
displayed a 6th/5th ratio above the 99.9% two-tailed confidence limit
(1.62 ratio value) determined analysing the response amplitudes to
control treatment with vehicle (further explanation in the text). 6th/5th
ratio distributions in control experiments on PKR1/ and WT
cultures had an identical distribution and 99.9% two-tailed confidence
limit (not shown) (n= 5 mice/genotype/dose).DISCUSSION
In this study, to better evaluate the involvement of the
prokineticin system in the neurobiology of pain, we
investigated the role of the prokineticin receptor 2
(PKR2) in pain perception, using pkr2- gene deficient
mice.
As previously established for pkr1-null mice (Negri
et al., 2006), we observed that mice lacking the pkr2 gene
exhibited several nociceptive deficits in response to ther-
mal noxious stimuli, to pro-algesic agents, and in inflam-
matory hyperalgesia when compared to wild type
littermates.
We found that pkr2-null mice exhibited reduced
nociceptive sensitivity to the noxious hot temperatures
of 46 C and 48 C, in the working range of C-polymodal
nociceptors and of TRPV1 channels (Le Bars et al.,
2001; Tominaga and Tominaga, 2005). Pkr2-null mice
were also less sensitive to the noxious cold temperature
of 4 C, in the working range of TRPA1 channels (Story
et al., 2003; del Camino et al., 2010; Knowlton et al.,
2010; Moran et al., 2011). Despite PKR2/ and WT
mice showed substantial differences in the thermal noci-
ceptive thresholds in the hot plate and in the tail-
immersion test, in the paw immersion test they showed
similar results, therefore suggesting that the response to
the different tests used may involve separate subpopula-
tions of nociceptors (Negri et al., 2006).
Conversely, as already observed in PKR1/ mice
(Negri et al., 2006), PKR2/mice did not show impaired
responsiveness to mechanical stimuli in basal conditions.
Moreover, we established that pkr2-null mice were
more resistant to nociceptive sensitization induced by
chemical and pro-algesic agents, and that PKR2/
mice exhibited impaired hyperalgesic responses to Bv8.
In line with RT-PCR studies on DRG neurons from
PKR2/ mice confirming the absence of PKR2
receptors, we deduce that the residual hyperalgesic
effect of Bv8 is explained by the presence of PKR1
receptors expressed in neurons able to induce the
typical biphasic hyperalgesia to thermal stimuli, but only
at doses 30 times higher compared to those sufficient in
WT mice. Interestingly, deletion of pkr2, but not of pkr1,
impaired Bv8-induced tactile allodynia, indicating the
Fig. 9. Summary of calcium imaging data in WT, PKR2/ and PKR1/ mice. (A) Percentage of cultured DRG neurons responsive to capsaicin
and mustard oil (MO). Pooled data from six cultures (WT, overall population of 3240 neurons) and five cultures from PKR2/ and PKR1/ (2288
and 2209 neurons, respectively). Percentages of capsaicin- and MO-responsive neurons in comparison to WT cultures were decreased by more
than 50% in PKR2/ cells, while in PKR1/ the decrease of MO-responsive neurons was limited to about a quarter. (B) Neuronal
subpopulations responsive to Bv8 either with a calcium signal or with sensitization to capsaicin. The percentages of Bv8-sensitive neurons and their
sub-fractions responsive to capsaicin were reduced in both PKR2/ and PKR1/ cultures by a fraction similar to the one of the overall
population (A). Differently, MO-responsive neurons were decreased in PKR2/ cultures (by almost 50%) while they were fractionally increased in
PKR1/ neurons, where they represented 76% of neurons expressing functional PKR2.
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stimuli. Disruption of pkr2 gene induced a strong
reduction of the capsaicin-induced paw licking response,
hyperalgesia and hypothermia, and reduced the acetic
acid-induced writhing responses. These observations
highlight a positive interaction between the G-protein-
coupled receptors PKR2 and the non-selective cation
channels TRPV1, which are activated by noxious heat
as well as by capsaicin and protons (Caterina et al.,
1997; Hu et al., 2006; Negri et al., 2006).
These data are in agreement with those already
acquired in pkr1-null mice (Negri et al., 2006) demonstrat-
ing an interaction between PKR1 and TRPV1, which are
co-expressed in a significant proportion of DRG small-
diameter neurons (Tominaga and Tominaga, 2005;
Lumpkin and Caterina, 2007). Results obtained in pkr2-
null mice suggest a similar positive functional cooperation
between PKR2 and TRPV1 in DRG small-sized neurons.
Nevertheless, PKR2 receptors are mainly present in
medium/large-sized neurons (Negri et al., 2006), and
are co-localized with TRPA1 (Dhaka et al., 2006; Vellani
et al., 2006).
Accordingly, in this paper we demonstrated that the
percentage of DRG neurons, from both pkr1- and
pkr2-null mice, that respond to Bv8 respond also to
capsaicin. Conversely, the percentage of DRG neurons
responsive to Bv8, which responded also to allyl
isothiocyanate, the pungent agent also termed mustardoil (a specific TRPA1 activator), was much higher in
PKR1/ than in PKR2/ mice, proving the
anatomical and functional colocalization between PKR2
and TRPA1. These data are supported also by in vivo
studies, which demonstrated that the PKR2/ mice
are far less sensitive to mustard oil-induced
hyperalgesia than WT mice.
The PKR2/TRPA1 functional co-localization is also
suggested by the substantially different formalin-induced
nocifensive behaviours between pkr2- and pkr1-null
mice. While in PKR2/ mice we observed a significant
reduction of both the first and the late phase of the
response to subcutaneous formalin administration, in
PKR1/ mice the reduction was detected only in the
first phase of the response. The two phases are caused
by two different mechanisms of action: the first phase is
predominantly due to the direct stimulation of peripheral
nociceptors, while the late phase involves both
peripheral inflammatory reactions and central functional
changes in the spinal cord (Tjølsen et al., 1992). TRPA1
channels localized in the periphery and in the spinal cord
participate to both the first and the secondary allodynia
and hyperalgesia: studies with TRPA1 antagonists and
TRPA1/ mice show impaired responses to formalin
(Colleen et al., 2007; McNamara et al., 2007; Rojas
et al., 2018). The lack of TRPA1, consequent to the lack
of PKR2 (with which it is colocalized), causes a significant
decrease in the early- and late-phase responses to forma-
D. Maftei et al. / Neuroscience 427 (2020) 16–28 27lin in PKR2/ mice. Conversely, the lack of TRPV1,
consequent to the lack of PKR1 (with which it is colocal-
ized), causes a significant reduction only in the early
phase responses to formalin in PKR1/ mice. These
data suggest that PKR2 receptors act at both peripheral
and spinal levels, while PKR1 preferentially act in the
periphery.
The notion of differential PKR1/2 sites of action is
supported also by experiments on inflammatory
hyperalgesia. We observed that both pkr2- and pkr1-null
mice show a reduced CFA-induced hyperalgesia, thus
indicating that both PKR2 and PKR1 receptors are
involved in chronic inflammatory pain. Indeed, chronic
inflammation is related to a robust upregulation of
PROK2, which, once released, interacts with both PKRs
on monocytes, macrophages and dendritic cells
secreting inflammatory mediators, as previously
demonstrated (Giannini et al., 2009).
However, only the disruption of PKR2 impaired the
development of CFA-induced tactile allodynia, because
tactile noxious stimuli are transmitted by Ad larger
diameter fibres, and the response involves processing
by central circuits (Klede et al., 2003), in accordance with
the prevalent distribution of PKR2 in the CNS (Chen et al.,
2002; Lin et al., 2002; Negri et al., 2007), and its putative
colocalization and cooperation with TRPA1 on medium/
large size sensory neurons.
These data are in line with recent data from our group
which demonstrate that the peripheral nerve damage was
able to upregulate PROK2 and PKR2 in the periphery as
well as in the spinal cord, and with the evidence that the
therapeutic administration of PC1, a prokineticin
receptor antagonist, alleviated thermal hyperalgesia and
delayed the development of tactile allodynia (Maftei
et al., 2014; Guida et al., 2015; Lattanzi et al., 2015), sup-
porting the notion that PKR2 is an inducible receptor, as
previously proposed (Kisliouk et al., 2005). PKR2 is nor-
mally expressed in spinal cord neurons and in some
medium-large DRG neurons, which also express the
vanilloid receptor TRPA1, an ion channel which is consid-
ered to play an important role in tactile allodynia (Nassini
et al., 2011). We therefore hypothesize that the increased
expression of PKR2 in nociceptors and in spinal cord neu-
rons associated with the increased expression of its ago-
nist PROK2, may play a crucial role in the induction and
maintenance of allodynia.
In conclusion, we demonstrated that PKR2 plays an
important role in setting the nociceptive threshold to
diverse noxious stimuli and that it is a critical mediator
of acute and chronic inflammatory hyperalgesia.
Given the interactions that we propose between PKR2
and TRP channels signalling in the development of pain, it
may be important to establish whether these interactions
are direct or indirect, with the aim of developing drugs
that, by targeting them, may have the potential to
achieve broad-spectrum analgesia.DECLARATIONS OF INTEREST
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